187 related articles for article (PubMed ID: 29317282)
1. Personal history of keratinocyte carcinoma is associated with reduced risk of death from invasive melanoma in men.
Song F; Chen ST; Li X; Han J
J Am Acad Dermatol; 2018 May; 78(5):957-963. PubMed ID: 29317282
[TBL] [Abstract][Full Text] [Related]
2. History of Keratinocyte Carcinoma and Risk of Melanoma: A Prospective Cohort Study.
Wu S; Cho E; Li WQ; Qureshi AA
J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376160
[TBL] [Abstract][Full Text] [Related]
3. Survival after squamous cell and basal cell carcinoma of the skin: A retrospective cohort analysis.
Rees JR; Zens MS; Celaya MO; Riddle BL; Karagas MR; Peacock JL
Int J Cancer; 2015 Aug; 137(4):878-884. PubMed ID: 25598534
[TBL] [Abstract][Full Text] [Related]
4. Risk of melanoma following keratinocyte malignancies.
Robinson SN; Zens MS; Rees JR; Barton DT; Karagas MR
Int J Cancer; 2020 Oct; 147(8):2116-2120. PubMed ID: 32285932
[TBL] [Abstract][Full Text] [Related]
5. Keratinocyte Carcinoma as a Marker of a High Cancer-Risk Phenotype.
Small J; Barton V; Peterson B; Alberg AJ
Adv Cancer Res; 2016; 130():257-91. PubMed ID: 27037755
[TBL] [Abstract][Full Text] [Related]
6. A skin cancer primer for primary care.
Buttolph G
JAAPA; 2001 Apr; 14(4):13-6, 21-2, 25-6. PubMed ID: 11521363
[No Abstract] [Full Text] [Related]
7. Risk of second primary cancer associated with pre-diagnostic smoking, alcohol, and obesity in women with keratinocyte carcinoma.
Park SM; Li T; Wu S; Li WQ; Qureshi AA; Stampfer M; Cho E
Cancer Epidemiol; 2017 Apr; 47():106-113. PubMed ID: 28242577
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutical options in malignant skin tumours].
Stanisz H; Tilgen W; Rass K
MMW Fortschr Med; 2009 Sep; 151(39):34-8. PubMed ID: 19831193
[No Abstract] [Full Text] [Related]
9. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
10. Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma.
Wehner MR; Linos E; Parvataneni R; Stuart SE; Boscardin WJ; Chren MM
JAMA Dermatol; 2015 Apr; 151(4):382-8. PubMed ID: 25588079
[TBL] [Abstract][Full Text] [Related]
11. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for keratinocyte skin cancer in patients diagnosed with melanoma, a large retrospective study.
Espinosa P; Pfeiffer RM; García-Casado Z; Requena C; Landi MT; Kumar R; Nagore E
Eur J Cancer; 2016 Jan; 53():115-24. PubMed ID: 26702765
[TBL] [Abstract][Full Text] [Related]
13. Survival of Patients with Cutaneous Squamous Cell Carcinoma: Results of a Prospective Cohort Study.
Eigentler TK; Leiter U; Häfner HM; Garbe C; Röcken M; Breuninger H
J Invest Dermatol; 2017 Nov; 137(11):2309-2315. PubMed ID: 28736229
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mucosal melanoma survival in a population-based setting.
Altieri L; Eguchi M; Peng DH; Cockburn M
J Am Acad Dermatol; 2019 Jul; 81(1):136-142.e2. PubMed ID: 30296542
[TBL] [Abstract][Full Text] [Related]
15. The effect of time to sentinel lymph node biopsy on cutaneous melanoma survival.
Fortes C; Mastroeni S; Caggiati A; Passarelli F; Zappalà A; Capuano M; Bono R; Nudo M; Marino C; Michelozzi P
Am J Surg; 2016 Nov; 212(5):935-940. PubMed ID: 27266393
[TBL] [Abstract][Full Text] [Related]
16. Functional status and survival in patients ≥85 years of age who have keratinocyte carcinoma: A retrospective cohort study.
Vora NB; Connolly KL; Dusza S; Rossi AM; Nehal KS; Lee EH
J Am Acad Dermatol; 2020 Aug; 83(2):463-468. PubMed ID: 32320764
[TBL] [Abstract][Full Text] [Related]
17. Opportunities for improving the efficiency of keratinocyte carcinoma care in primary and specialist care: Results from population-based Dutch cohort studies.
Wakkee M; van Egmond S; Louwman M; Bindels P; van der Lei J; Nijsten T; Hollestein L
Eur J Cancer; 2019 Aug; 117():32-40. PubMed ID: 31229947
[TBL] [Abstract][Full Text] [Related]
18. The presence of betapapillomavirus antibodies around transplantation predicts the development of keratinocyte carcinoma in organ transplant recipients: a cohort study.
Genders RE; Mazlom H; Michel A; Plasmeijer EI; Quint KD; Pawlita M; van der Meijden E; Waterboer T; de Fijter H; Claas FH; Wolterbeek R; Feltkamp MCW; Bouwes Bavinck JN
J Invest Dermatol; 2015 May; 135(5):1275-1282. PubMed ID: 25347116
[TBL] [Abstract][Full Text] [Related]
19. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
[TBL] [Abstract][Full Text] [Related]
20. Competing risk analysis of mortality from invasive cutaneous melanoma in New South Wales: a population-based study, 1988-2007.
Marashi-Pour S; Morrell S; Cooke-Yarborough C; Arcorace M; Baker D
Aust N Z J Public Health; 2012 Oct; 36(5):441-5. PubMed ID: 23025365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
